BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 16247563)

  • 21. Age of onset of substance use and psychosocial problems among individuals with substance use disorders.
    Poudel A; Gautam S
    BMC Psychiatry; 2017 Jan; 17(1):10. PubMed ID: 28077106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review.
    Prat G; Marquez-Arrico JE; Río-Martínez L; Navarro JF; Adan A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110310. PubMed ID: 33775743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlates of mental health service use intensity in the National Comorbidity Survey and National Comorbidity Survey Replication.
    Elhai JD; Ford JD
    Psychiatr Serv; 2007 Aug; 58(8):1108-15. PubMed ID: 17664523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders: findings from the "Psychiatric and Addictive Dual Disorder in Italy (PADDI)" Study.
    Carrà G; Crocamo C; Borrelli P; Popa I; Ornaghi A; Montomoli C; Clerici M
    Compr Psychiatry; 2015 Apr; 58():152-9. PubMed ID: 25591906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients.
    Zhornitsky S; Rizkallah E; Pampoulova T; Chiasson JP; Lipp O; Stip E; Potvin S
    Psychiatry Res; 2012 Dec; 200(2-3):237-41. PubMed ID: 22980481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The consequences of Conduct Disorder for males who develop schizophrenia: associations with criminality, aggressive behavior, substance use, and psychiatric services.
    Hodgins S; Tiihonen J; Ross D
    Schizophr Res; 2005 Oct; 78(2-3):323-35. PubMed ID: 15996855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schizophrenia and serious violence: a clinical-profile analysis incorporating impulsivity and substance-use disorders.
    Dumais A; Potvin S; Joyal C; Allaire JF; Stip E; Lesage A; Gobbi G; Côté G
    Schizophr Res; 2011 Aug; 130(1-3):234-7. PubMed ID: 21441016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulant use disorders: characteristics and comorbidity in an Australian population sample.
    Sara G; Burgess P; Harris M; Malhi GS; Whiteford H; Hall W
    Aust N Z J Psychiatry; 2012 Dec; 46(12):1173-81. PubMed ID: 22990432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurobiological underpinnings and modulating factors in schizophrenia spectrum disorders with a comorbid substance use disorder: A systematic review.
    Adan A; Arredondo AY; Capella MD; Prat G; Forero DA; Navarro JF
    Neurosci Biobehav Rev; 2017 Apr; 75():361-377. PubMed ID: 28188887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A national study of violent behavior in persons with schizophrenia.
    Swanson JW; Swartz MS; Van Dorn RA; Elbogen EB; Wagner HR; Rosenheck RA; Stroup TS; McEvoy JP; Lieberman JA
    Arch Gen Psychiatry; 2006 May; 63(5):490-9. PubMed ID: 16651506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in substance use, psychiatric disorders and social factors between Mexican adolescents and young adults.
    Tejeda-Romero C; Kobashi-Margáin RA; Alvarez-Arellano L; Corona JC; González-García N
    Am J Addict; 2018 Dec; 27(8):625-631. PubMed ID: 30265430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.
    Krystal JH; D'Souza DC; Gallinat J; Driesen N; Abi-Dargham A; Petrakis I; Heinz A; Pearlson G
    Neurotox Res; 2006 Dec; 10(3-4):235-52. PubMed ID: 17197373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-medication of mental health problems: new evidence from a national survey.
    Harris KM; Edlund MJ
    Health Serv Res; 2005 Feb; 40(1):117-34. PubMed ID: 15663705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder.
    Bhalla IP; Stefanovics EA; Rosenheck RA
    Med Care; 2017 Sep; 55 Suppl 9 Suppl 2():S24-S32. PubMed ID: 28806363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns and quality of treatment for patients with schizophrenia in routine psychiatric practice.
    West JC; Wilk JE; Olfson M; Rae DS; Marcus S; Narrow WE; Pincus HA; Regier DA
    Psychiatr Serv; 2005 Mar; 56(3):283-91. PubMed ID: 15746502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do individuals with a severe mental illness experience greater alcohol and drug-related problems? A test of the supersensitivity hypothesis.
    Gonzalez VM; Bradizza CM; Vincent PC; Stasiewicz PR; Paas ND
    Addict Behav; 2007 Mar; 32(3):477-90. PubMed ID: 16828977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substance use disorders increase the odds of subsequent mood disorders.
    Kenneson A; Funderburk JS; Maisto SA
    Drug Alcohol Depend; 2013 Dec; 133(2):338-43. PubMed ID: 23906994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients.
    Havassy BE; Arns PG
    Psychiatr Serv; 1998 Jul; 49(7):935-40. PubMed ID: 9661229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical diagnosis of substance use disorders in private psychiatric populations.
    Miller NS; Belkin BM; Gibbons R
    J Subst Abuse Treat; 1994; 11(4):387-92. PubMed ID: 7966510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.